Table 1.
Case-control studies investigating the effect of haemoglobinopathies on P. falciparum malaria
| Source | Location | Syndromea | No. patients | Age | Comment | % Haemoglobin opathy |
|---|---|---|---|---|---|---|
| Haemoglobin AS | ||||||
| Gilles et al (1967)16 | Nigeria | Severe malaria | 100 | Range 6m - 4y | 4.0 | |
| Healthy | 100 | Range 6m - 4y | Aparasitaemic outpatients | 18.0 | ||
| Willcox et al (1983)33 | Liberia | Uncomplicated malaria | 518 | Range 2m - >15y | Outpatients | 1.9 |
| Healthy | 1027 | Range 2m - >15y | Community surveys | 7.9 | ||
| Hill et al (1991)22 | The Gambia | Severe malaria | 619 | Median 3.0y Range <10y |
1.2 | |
| Severe non-malaria illness | 332 | Median 2.2y Range <10y |
Inpatients with severe non- malaria illness | 10.9 | ||
| Mild non-malaria illness | 510 | Median 1.9y Range <10y |
Mild outpatient illness without malaria parasites | 12.9 | ||
| Uncomplicated malaria | 354 | Median 3.0y Range <10y |
2.8 | |||
| Agarwal et al (2000)21 | Mali | Severe malaria | 67 | Mean 4.3y | 4.5 | |
| Cerebral malaria | 34 | Mean 3.8y | Subset of severe malaria patients with coma, obtundation, or convulsions | 5.9 | ||
| Severe malarial anaemia | 12 | Mean 1.0y | Subset of severe malaria patients with Hct <15% | 0 | ||
| Uncomplicated malaria | 391 | Mean 9.1y | 2.7 | |||
| Modiano et al (2001)17 | Burkina Faso | Severe malaria | 359 | Mean 4y Range 0.5 -15y |
1.1 | |
| Uncomplicated malaria | 476 | Mean 4y Range 0.5 -15y |
4.0 | |||
| Healthy | 3513 | Mean 11y Range 1- 40y |
Community cross-sectional survey | 9.5 | ||
| Mockenhaupt et al (2004)20 | Ghana | Severe malaria | 290 | Median 24m Range 6 - 102m |
0 | |
| Healthy, parasitaemic | 290 | NA | Community cross-sectional survey, matched to severe cases | 7.9 | ||
| Healthy aparasitaemic | 290 | NA | Community cross-sectional survey, matched to severe cases | 8.3 | ||
| Ackerman et al (2005)18 | The Gambia | Severe malaria | 315 | NA | 1.1 | |
| Cerebral malaria | 235 | NA | Subset of severe malaria patients with BCS <3 | 1.3 | ||
| Severe malarial anaemia | 80 | NA | Subset of severe malaria patients with Hb <5g/dL | 0.6 | ||
| Newborns | 583 | NA | Cord blood specimens | 8.7 | ||
| May et al (2007)19 | Ghana | Severe malaria | 2591 | Median 20m | 1.4 | |
| Cerebral malaria | 581 | NA | Subset of severe malaria patients with BCS <3 | 1.2 | ||
| Severe malarial anaemia | 1649 | NA | Subset of severe malaria patients with Hb <5g/dL | 1.6 | ||
| Healthy | 2048 | Median 30m | Community cross-sectional survey, matched to severe cases | 14.8 | ||
| Jallow et al (2009)99 | The Gambia | Severe malaria | 1060 | NA | NA | |
| Cerebral malaria | 869 | NA | Subset of severe malaria patients with BCS <3 | NA | ||
| Severe malarial anaemia | 318 | NA | Subset of severe malaria patients with Hb <5g/dL | NA | ||
| Newborns | 1500 | NA | Cord blood specimens | 8.0 | ||
| Haemoglobin C | ||||||
| Gilles et al (1967)16 | Nigeria | Severe malaria | 100 | Range 6m - 4y | He: 6.0 | |
| Healthy | 200 | Range 6m - 4y | Clinic attendance, aparasitaemic | He: 7.0 | ||
| Willcox et al (1983)33 | Liberia | Uncomplicated malaria | 518 | Range 2m - >15y | He: 1.3 | |
| Healthy | 1027 | Range 2m - >15y | Community surveys | He: 0.4 | ||
| Guinet et al (1997)26 | Mali | Severe malaria | 110 | Range 6m - 9y | 10.0 | |
| Severe malarial anaemia | 6 | Range 6m - 9y | Subset of severe malaria patients with Hct <15% or Hb <5g/dL | 0 | ||
| Uncomplicated malaria | 55 | Range 6m - 9y | Matched to severe cases | 9.0 | ||
| Agarwal et al (2000)21 | Mali | Severe malaria | 67 | Mean 4.3y | Ho: 0 He: 4.5 |
|
| Cerebral malaria | 34 | Mean 3.8y | Subset of severe malaria patients with coma, obtundation, or convulsions | Ho: 0 He: 2.9 |
||
| Severe malarial anaemia | 12 | Mean 1.0y | Subset of severe malaria patients with Hct <15% | Ho: 0 He: 0 |
||
| Uncomplicated malaria | 391 | Mean 9.1y | Ho: 1.5 He: 15.9 |
|||
| Modiano et al (2001)17 | Burkina Faso | Severe malaria | 359 | Mean 4y Range 0.5 – 15y |
Ho: 0.3 He: 17.6 |
|
| Uncomplicated malaria | 476 | Mean 4y Range 0.5 – 15y |
Ho: 0 He: 15.6 |
|||
| Healthy | 3513 | Mean 11y Range 1- 40y |
Community cross-sectional survey | Ho: 1.7 He: 21.7 |
||
| Mockenhaupt et al (2004)20 | Ghana | Severe malaria | 290 | Median 24m Range 6 – 102m |
Ho: 0 He: 16.6 |
|
| Healthy, parasitaemic | 290 | NA | Community cross-sectional survey, matched to severe cases | Ho: 1.0 He: 24.5 |
||
| Healthy, aparasitaemic | 290 | NA | Community cross-sectional survey, matched to severe cases | Ho: 1.7 He: 19.0 |
||
| May et al (2007)19 | Ghana | Severe malaria | 2591 | Median 20m | Ho: 0.2 He: 9.4 |
|
| Cerebral malaria | 581 | NA | Subset of severe malaria patients with BCS <3 | Ho: NA He: 7.2 |
||
| Severe malarial anaemia | 1649 | NA | Subset of severe malaria patients with Hb <5g/dL | Ho: NA He: 9.2 |
||
| Healthy | 2048 | Median 30m | Community cross-sectional survey, matched to severe cases | Ho: 0.5 He: 8.7 |
||
| Haemoglobin E | ||||||
| Oo et al (1995)27 | Myanmar | Severe malaria | 200 | 19 - 45y | 28.0 | |
| Uncomplicated malaria | 109 | 19 - 45y | Hospitalized | 27.5 | ||
| Hutagalung et al (1999)28 | Thailand | Severe malaria | 33 | 14 - 45y | 3.0 | |
| Uncomplicated malaria | 184 | 14 - 45y | Hospitalized | 22.3 | ||
| α-thalassaemia | ||||||
| Allen et al (1997)29 | Papua New Guinea | Severe malaria | 249 | NA | Ho: 44.6 He: 37.3 |
|
| Severe malarial anaemia | 155 | Median 2.1y | Subset of severe malaria patients with Hb <5g/dL | Ho: 36.1 He: 43.9 |
||
| Healthy | 249 | NA | Community survey, matched to severe cases | Ho: 57.0 He: 31.3 |
||
| Lell et al (1999)100 | Gabon | Severe malaria | 100 | Mean 44m | Ho: 10.0 He: 37.0 |
|
| Uncomplicated malaria | 100 | Mean 44m | Ho: 10.0 He: 43.0 |
|||
| Mockenhaupt et al (2004)30 | Ghana | Severe malaria | 261 | <5y | Ho: 5.0 He: 23.7 |
|
| Healthy, parasitaemic | 614 | <5y | Community cross-sectional survey, matched to severe cases | Ho: 3.3 He: 33.2 |
||
| Healthy, aparasitaemic | 479 | <5y | Community cross-sectional survey, matched to severe cases | Ho: 3.6 He: 31.9 |
||
| Williams et al (2005)31 | Kenya | Severe malaria | 655 | NA | Ho: 12.7 He: 47.0 |
|
| Fatal malaria | 72 | NA | Death in hospital | Ho: 8.4 He: 10.4 |
||
| Healthy | 648 | <7y | Community survey, matched | Ho: 16.7 He: 50.6 |
||
| May et al (2007)19 | Ghana | Severe malaria | 2591 | Median 20m | Ho: 2.0 He: 25.2 |
|
| Cerebral malaria | 581 | NA | Subset of severe malaria patients with BCS <3 | Ho: 2.2 He: 23.8 |
||
| Severe malarial anaemia | 1649 | NA | Subset of severe malaria patients with Hb <5g/dL | Ho: 1.8 He: 24.7 |
||
| Healthy | 2048 | Median 30m | Community cross-sectional survey, matched to severe cases | Ho: 2.0 He: 27.3 |
||
| β-thalassaemia | ||||||
| Willcox et al (1983)33 | Liberia | Uncomplicated malaria | 526 | 2m - >15y | 5.7 | |
| Healthy | 1132 | 2m - >15y | Community surveys | 9.7 | ||
Abbreviations: Hb: haemoglobin; NA: data not available; Ho: homozygote; He: heterozygote; BCS: Blantyre Coma Score; Hct: hematocrit.
Unless otherwise stated, patients with severe malaria, severe malarial anaemia, cerebral malaria and uncomplicated malaria met definitions described in the Methods section. Healthy patients were recruited as described in the Comments column.